Approaching Malignant Lymphedema: A Case Report
Received: Mar 09, 2023; Accepted: May 26, 2023
Published Online: May 31, 2023
Abstract
When managing cancer-related lymphedema, physicians should discriminate between benign and malignant types. Benign lymphedema could be solely treated by complex decongestive therapy. However, approach for malignant lymphedema should focus on the treatment of progressed cancer. Despite a lack of research on the assessment tools, identifying malignant lymphedema is important. We report a case of an intractable lymphedema patient whose lymphedema was previously assessed as benign. She was newly diagnosed with malignant lymphedema by computed tomography and showed significant improvement after chemoradiotherapy. This case report shows the clinical significance of CT venography for assessing malignant lymphedema in intractable lymphedema patients.
Metrics
QR Code of this Article:
Related Articles
Venous Disease Related Lymphedema - Phlebolymphedema
Clin. Lymphology Lymphedema 2018;3(1):10-14.
Photo-physical and -Chemical Effects of Low-level LASER on Lymphedema Treatment
Clin. Lymphology Lymphedema 2025;10(2):31-35.
Practical Exercise Program for Patients with Lymphedema
Clin. Lymphology Lymphedema 2025;10(2):36-42.
Current Challenges and Future Directions in Lymphedema Diagnosis and Staging
Clin. Lymphology Lymphedema 2025;10(2):48-52.
Analysis of Predictive Factors for Arm Lymphedema Following Salvage Radiotherapy for Patients with Recurrent Breast Cancer
Clin. Lymphology Lymphedema 2025;10(2):53-62.
